marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Crinetics Pharmaceuticals Bilanz 2011-2024 | CRNX
Bilanz Jährlich Crinetics Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-3.17 M | -29.6 M | -198 M | -89.1 M | -35.5 M | -45 M | -14.2 M | -11.9 M | - | - | - | - | - |
Langfristige Schulden |
47.6 M | 2.02 M | 3.07 M | 4.01 M | - | - | - | 163 K | - | - | - | - | - |
Langfristiger Schuldenstrom |
4.17 M | 1.05 M | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 4.9 M | 3.26 M | 29.7 M | 17.9 M | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
43.9 M | 27.7 M | 16 M | 10.5 M | 8.34 M | 7.92 M | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
96.2 M | 35.8 M | 19.1 M | 14.5 M | 13.2 M | 11.2 M | 30.6 M | 18.8 M | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-654 M | -439 M | -275 M | - | -93.8 M | -43.4 M | -16.3 M | -7.11 M | - | - | - | - | - |
Vermögenswerte |
635 M | 352 M | 351 M | 183 M | 130 M | 171 M | 15.6 M | 12.6 M | - | - | - | - | - |
Zahlungsmittel |
54.9 M | 32.7 M | 201 M | 93.1 M | 40.3 M | 45 M | 14.2 M | 12.2 M | - | - | - | - | - |
Buchwert |
539 M | 316 M | 332 M | 169 M | 117 M | 160 M | -15 M | -6.2 M | - | - | - | - | - |
Gesamtes Eigenkapital |
539 M | 316 M | 332 M | 169 M | 117 M | 160 M | -15 M | -6.2 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Crinetics Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
45.1 M | 45.9 M | 46.7 M | 47.6 M | 48.2 M | 1.46 M | 1.74 M | 2.02 M | 2.3 M | 2.56 M | 2.82 M | 3.07 M | 3.32 M | 3.56 M | 3.79 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.85 M | 4.85 M | 4.85 M | 4.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
104 M | 105 M | 103 M | 96.2 M | 93.8 M | 39.1 M | 33.7 M | 35.8 M | 33.5 M | 35.6 M | 30.2 M | 19.1 M | 15.8 M | 15.5 M | 14.1 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 920 K | 920 K | 920 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
1.68 M | 2.56 M | - | 2.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-872 M | -795 M | -721 M | -654 M | -594 M | -536 M | -485 M | -439 M | -394 M | -352 M | -310 M | -275 M | -244 M | -217 M | -191 M | -168 M | -168 M | -168 M | -168 M | -93.8 M | -93.8 M | -93.8 M | -93.8 M | -43.4 M | -43.4 M | -43.4 M | -43.4 M | -16.3 M | -16.3 M | -16.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
937 M | 936 M | 978 M | 635 M | 642 M | 293 M | 314 M | 352 M | 385 M | 422 M | 333 M | 351 M | 209 M | 217 M | 164 M | 183 M | 183 M | 183 M | 183 M | 130 M | 130 M | 130 M | 130 M | 171 M | 171 M | 171 M | 171 M | 15.6 M | 15.6 M | 15.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
317 M | 302 M | 396 M | 54.9 M | 143 M | 39.6 M | 41.2 M | 32.7 M | 30.9 M | 62.3 M | 146 M | 201 M | 162 M | 179 M | 106 M | 93.1 M | 93.1 M | 93.1 M | 93.1 M | 40.3 M | 40.3 M | 40.3 M | 40.3 M | 45 M | 45 M | 45 M | 45 M | 14.2 M | 14.2 M | 14.2 M | - | 12.2 M | - | - | - | 17.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
833 M | 831 M | 875 M | 539 M | 548 M | 254 M | 280 M | 316 M | 351 M | 386 M | 303 M | 332 M | 194 M | 201 M | 149 M | 169 M | 169 M | 169 M | 169 M | 117 M | 117 M | 117 M | 117 M | 160 M | 160 M | 160 M | 160 M | 14.7 M | 14.7 M | 14.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
833 M | 831 M | 875 M | 539 M | 548 M | 254 M | 280 M | 316 M | 351 M | 386 M | 303 M | 332 M | 194 M | 201 M | 149 M | 169 M | 169 M | 169 M | 169 M | 117 M | 117 M | 117 M | 117 M | 160 M | 160 M | 160 M | 160 M | -15 M | -15 M | -15 M | - | -6.2 M | - | - | - | -463 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung